Recent developments span from pharma mergers and vaccination campaigns to advancements in chronic disease management and pediatric health research.

Nearly 90,000 young people in England received their first dose of the MenB vaccine within a two-week period, with over 135,000 additional appointments scheduled.

AstraZeneca is reportedly in discussions regarding a potential 300 billion pound merger with Bristol Myers Squibb, a deal that would create one of the largest pharmaceutical entities globally.

A phase 2 study suggests that intravenous vitamin C combined with chemotherapy may extend overall survival rates in cancer patients, though experts call for larger randomized trials.

New research indicates that a remotely supervised high-intensity interval training (HIIT) program helps adolescents with obesity sustain weight loss and fitness improvements for at least one year.

A study on migraine treatment demonstrates that intravenous eptinezumab effectively reduces migraine days for patients who have previously failed at least three prophylactic treatments.

Medical experts are debating the optimal multidisciplinary care models for thyroid eye disease in the era of targeted biologics.

Preschoolers with higher consumption of ultraprocessed foods are more likely to have excessive screen time and fail to meet recommended daily activity levels.

Patients with underlying cardiovascular disease face a significantly higher risk of hospitalization following episodes of acute gastroenteritis.